As theprognostic value of a loss of stromal Cav-1 was independent of epithelialmarker status, it appears that a loss of Cav-1 has predictive value in all thedifferent epithelial subtypes of human breast cancer, including ER+, PR+,HER2+, and triple-negative patients [4]. The gene discussed is CAV1; the disease is breast cancer.